The LAM Foundation

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1995

Legal Domicile

Phone

5137776889

Tax Period

2024-01-01 to 2024-12-31

The LAM Foundation, founded in 1995, is a community nonprofit in the Philanthropy & Grantmaking sector that reported $1.9M in total revenue in fiscal year 2024. Revenue surged 32% from the prior year, signaling strong growth momentum. The organization ran a surplus of $330K, a strong 17% operating margin.

Mission

The LAM Foundation urgently seeks safe and effective treatments and ultimately a cure for LAM.

Program Service Accomplishments

Program 1

Expenses: $676,813

Research Costs The LAM Foundation awarded $424,603 to fund five new research projects in 2024. The Foundation continued to fund eight active grants which had been approved in prior years. The LAM...

Research Costs The LAM Foundation awarded $424,603 to fund five new research projects in 2024. The Foundation continued to fund eight active grants which had been approved in prior years. The LAM Patient Research Priorities (LAM PREP) survey collected more than 750 responses from patients, their loved ones, scientists and clinicians. The LAM Foundation Early Career Network (TEN) met on three occasions providing a unique environment for young investigators to discuss their LAM research and career goals.

Program 2

Expenses: $391,703

Patient Services In collaboration with our LAM clinic directors, liaisons and scientists we offered 34 virtual events, including LAMposium in Your Living Room webinars, education meetings, and social gatherings. More than 1,000 members of our global community attended our virtual events, and the recorded presentation received over 5700 viewings, further spreading LAM education and awareness around the globe. More than 255 individuals registered with the Foundation. Nine Circle of Hope Transplant Support Program participants received lung transplants this year, resulting in more than 38 tissue samples to further LAM research.

Program 3

Expenses: $86,226

Clinical The LAM Clinic & Research Network continues to expand and provide locally based, expert care for women with LAM around the world. We added one clinic in 2024: Oslo, Norway. The LAM...

Clinical The LAM Clinic & Research Network continues to expand and provide locally based, expert care for women with LAM around the world. We added one clinic in 2024: Oslo, Norway. The LAM Foundation hosted more than 50 members of the LAM Clinic and Research Network at the LAM Foundation luncheon at the ATS Conference in San Diego, CA.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,811,620

Program Service Revenue $0

Investment Income $102,577

Other Revenue $8,213

TOTAL REVENUE $1,922,410

Expense Breakdown

Grants Paid $339,630

Salaries & Benefits $550,207

Fundraising Expenses $242,147

Program Expenses $1,154,742

Other Expenses $702,926

TOTAL EXPENSES $1,592,763

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,922,410	$1,455,589	+0.3%
Expenses	$1,592,763	$1,803,072	-0.1%
Net Income	$329,647	$-347,483	-1.9%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

150

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Vera Krymskaya PhD	Vice Chair	1.00	Officer Director	$0	$0	$0
Andrew Romanosky	Treasurer	1.00	Officer Director	$0	$0	$0
Greg Downey MD	Director	1.00	Director	$0	$0	$0
Dan Dilling MD	Director	1.00	Director	$0	$0	$0
Pat Venters	Director	1.00	Director	$0	$0	$0
Stephanie Nemser-Dreyer	Vice Chair	1.00	Officer Director	$0	$0	$0
Chuck Wehland	Chairman	1.00	Officer Director	$0	$0	$0
Dr Lyndsay Hoy	Vice Chair	1.00	Officer Director	$0	$0	$0
Eden Pontz	Secretary	1.00	Officer Director	$0	$0	$0
Stephanie Hammes MD PcD	Director	1.00	Director	$0	$0	$0
Christine Krueger	Director	1.00	Director	$0	$0	$0
Andrea Slattery	Vice Chair	1.00	Officer Director	$0	$0	$0
Kaela Varberg	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,922,410	$1,592,763	$2,870,285	$329,647
2023	$1,455,589	$1,803,072	$2,596,985	$-347,483
2022	$1,571,673	$1,873,408	$2,903,030	$-301,735
2021	$2,209,585	$1,346,515	$3,219,008	$863,070
2020	$1,815,339	$1,611,773	$2,357,161	$203,566
2019	$1,389,662	$1,524,952	$2,217,979	$-135,290
2018	$1,849,309	$1,745,000	$2,350,912	$104,309